Mumbai, July 3 -- Emcure Pharmaceuticals announced that Marcan Pharmaceuticals Inc., a subsidiary of the Company (Marcan) has on 02 July 2026 (EDT) entered into share purchase agreements with certain shareholders of Mantra Pharma Inc., a step-down subsidiary of the Company (Mantra), to acquire all of Class E Special Shares in the share capital of Mantra for an aggregate consideration of CAD $ 50 million. Consequently, Mantra continues to be 100% subsidiary of Marcan.

Published by HT Digital Content Services with permission from Capital Market....